Trustpilot rating: 4.5 stars (out of 5.0 stars) based on 8,390 user reviews (January 8, 2026)
In this guide, you will find: The dose ranges evaluated so far (112 mg weekly) How gradual titration influences outcomes and side-effect management Key distinctions between Retatrutide and other GLP-1/GIP agonists What upcoming data may suggest about its clinical and real-world potential Key Takeaways Retatrutide is an investigational triple-agonist medication that activates GLP-1, GIP, and glucagon receptors to improve metabolism and reduce appetite
The 99%+ purity standard maintained by PSPeptides ensures that research outcomes reflect the genuine pharmacology of retatrutide rather than impurity-related artifacts
Each participant was assessed by waist circumference measurements
In addition, semaglutide use was linked with a lower risk of substance use disorders
While its not an instant energy boost, this balance can help you feel more consistent vitality, supporting your overall well-being and enhancing your quality of life